Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.

Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

"Kidneys" Том 9, №4, 2020

Back to issue

KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

Summary of recommendation statements and practice points 

Chapter 1: Comprehensive care in patients with diabetes and CKD 

1.1 Comprehensive diabetes and CKD management Practice 
Practice Point 1.1.1: Patients with diabetes and chronic kidney disease (CKD) should be treated with a comprehensive strategy to reduce risks of kidney disease progression and cardiovascular disease (Figure 2).
1.2 Renin-angiotensin system (RAS) blockade
Recommendation 1.2.1: We recommend that treatment with an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin II receptor blocker (ARB) be initiated in patients with diabetes, hypertension, and albuminuria, and that these medications be titrated to ...

For the full article you need to subscribe to the magazine.


Similar articles

Next Step in Chronic Kidney Disease Therapy
Authors: Ivanov D.D. - National Medical Academy of Postgraduate Education named after P.L. Shupyk, Department of Nephrology and Renal Replacement Therapy, Kyiv, Ukraine
"Kidneys" 2 (16) 2016
Date: 2016.05.19
Categories: Nephrology
Sections: Specialist manual
The impact of urate-lowering therapy on kidney function (IMPULsKF)
Authors: D.D. Ivanov Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
"Kidneys" Том 6, №2, 2017
Date: 2017.06.08
Categories: Nephrology
Sections: Specialist manual
When Should We Start Using Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers  in Diabetic Kidney Disease?
Authors: D.D. Ivanov
Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine

"Kidneys" Том 6, №1, 2017
Date: 2017.03.09
Categories: Nephrology
Sections: Specialist manual

Back to issue